Bloom Labs Bio has filed a notice of an exempt offering of securities to raise $2,805,350.00 in New Debt Financing.
According to filings with the U.S. Securities and Exchange Commission, Bloom Labs Bio is raising $2,805,350.00 in new funding. Sources indicate that as part of senior management Chief Executive Officer, Simardev Gulati played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.
About Bloom Labs Bio
Bloom Labs is pioneering breakthrough in material science by harnessing the value of natural waste by-products, a protein-rich and globally abundant raw material, to create high-performance alternatives to textile and plastic materials. Our mission is to make circularity an actuality. We see a future where old resource-intensive processes are replaced with cutting-edge next-gen alternatives. Using bio-manufacturing, advanced protein engineering, and molecular biology, our proprietary technology plasticizes waste, regenerating it into uniquely practical and versatile pellets. The pellets are spun into high-performance fibers, designed to emulate the properties of current market-leading materials as plush as cotton, as lush as silk, and as functional as polyester. These materials are scalable and commercially viable yet avoid the use of harmful petrochemicals and resource-intensive processes. Our expert team of interdisciplinary scientists is reimagining material sourcing for multiple sectors and developing commercially feasible alternatives which will create a future of seamless integration, infinite feedstock, and limitless possibilities.
To learn more about Bloom Labs Bio, visit http://www.bloomlabs.bio/
Contact:
Simardev Gulati, Chief Executive Officer
516-263-7006
SOURCE: http://www.intelligence360.io
Copyright (c) 2024 SI360 Inc. All rights reserved.